Metapneumovirus infection

2 trials MedDRA PT
2 Registered trials
0 Recruiting
2 Unique sponsors
1 Unique IMPs
2 Commercial trials
Drug classes (ATC)
ATC code not specified 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase III: 1 Phase I (Other): 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • AstraZeneca AB Commercial
    IVX-121, HUMAN METAPNEUMOVIRUS, VIRUS-LIKE PROTEIN
    2024-513740-28-00 8 countries n=3,714
    Pending

Phase I (Other)

1 trial
  • NextCell Pharma AB Commercial
    IMP not specified
    2024-519391-11-00 1 country n=9
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
NextCell Pharma AB Commercial 1 Phase I (Other) 0
AstraZeneca AB Commercial 1 Phase III 0
← All indication landscapes